...
首页> 外文期刊>Research journal of pharmacy and technology >Controlled release Microcapsules for Oral Delivery of Aceclofenac: Formulation and Characterization
【24h】

Controlled release Microcapsules for Oral Delivery of Aceclofenac: Formulation and Characterization

机译:口服口服醋氯芬酸的控释微胶囊:配方与表征

获取原文
获取原文并翻译 | 示例

摘要

The aim of the present research work was to formulate microcapsules for rate controlled oral delivery of aceclofenac, using cellulose acetate phthalate (CAP) and ethyl cellulose (EC) as release retardant, and to evaluate the physicochemical properties. 'Polymer deposition by emulsion-solvent evaporation' technique was employed to produce microcapsules with CAP alone and with different proportions of CAP and EC, using acetone to dissolve the polymers. The formulations were characterized in terms of particle size, morphology, drug loading, -entrapment efficiency, nature of flow and drag release. Infrared spectra and differential scanning thermograms confirmed the compatibility of drag with excipients and formulation process. Microcapsules were uniform, spherical, discrete and free flowing with the particle size varying from 397.32 to 526.06 urn. Average particle size increased with increase in proportion of polymer. High drug loading (19.12% to 42.84%) and entrapment efficiency (76.48% to 85.68%) were achieved, both the parameters decreasing with increasing fraction of polymer. The results of powder flow parameters like angle of repose, bulk density, tapped density, compressibility index and Hausner ratio confirmed that the powder was free flowing to enable direct capsule filling. The rate of drag release from microcapsules was found to be inversely related to the proportion of polymer. Substitution of a fraction of CAP with EC further slowed down the drug release rate, but the drag release was above 80% after 8 h. The drug release was dependent on concentration of aceclofenac in the core, with super case II transport mechanism. Delayed controlled release microcapsules of aceclofenac were successfully developed using ethyl cellulose and cellulose acetate phthalate, suitable for oral delivery.
机译:本研究工作的目的是使用醋酸邻苯二甲酸纤维素(CAP)和乙基纤维素(EC)作为释放抑制剂,配制用于控制醋氯芬酸口服速率的微胶囊,并评估其理化性质。采用“通过乳液-溶剂蒸发的聚合物沉积”技术,用丙酮溶解聚合物,制得仅含CAP以及不同比例的CAP和EC的微胶囊。根据粒径,形态,药物载量,包埋效率,流动性质和药物释放特性对制剂进行表征。红外光谱和差示扫描热分析图证实了药物与赋形剂和配制过程的相容性。微胶囊是均匀的,球形的,离散的和自由流动的,其粒径在397.32至526.06 um之间变化。平均粒径随着聚合物比例的增加而增加。实现了高载药量(19.12%至42.84%)和包封率(76.48%至85.68%),这两个参数均随聚合物分数的增加而降低。粉末流动参数(如休止角,堆积密度,堆积密度,可压缩指数和Hausner比)的结果证实粉末可以自由流动以直接填充胶囊。发现从微胶囊释放药物的速率与聚合物的比例成反比。用EC代替一小部分CAP进一步减缓了药物释放速度,但8小时后药物释放超过80%。药物释放取决于核心中醋氯芬酸的浓度,并具有超级案例II转运机制。使用乙基纤维素和邻苯二甲酸乙酸纤维素成功开发了醋氯芬酸缓控释微胶囊,适合口服给药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号